Achieving early insights into a new drug launch
After releasing a new drug for HCV, our client wanted to be able to regularly track uptake of their product.
They wanted to see how the market would react to the new drug and gain quantitative insight into breadth of prescribing, patient profiles and segments, and identify changes in prescribing behaviour over time as soon as possible.
Therapy Watch launches Lupus, a new patient tracking study
Recently, we’ve seen a change in the treatment landscape for lupus with biologics increasingly being used to control the disease. In light of this, and because of client demand, we are expanding our portfolio of autoimmune products to now include Therapy Watch Lupus.
To keep in step with the market dynamics as they happen, Therapy Watch Lupus will be a quarterly study amongst 280 rheumatologists across France, Germany, Italy, Brazil, Canada and the US, submitting information on 2,000+ patients each wave.